Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting
Marcello Rotta(Colorado Blood Cancer Institute), David G. Maloney(Fred Hutch Cancer Center), Judith A. Shizuru(Stanford University), Firoozeh Sahebi(City Of Hope National Medical Center), Parameswaran Hari(Medical College of Wisconsin), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Thomas R. Chauncey(City Of Hope National Medical Center), Thoralf Lange, Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Barry E. Storer(City Of Hope National Medical Center), Richard T. Maziarz(Oregon Health & Science University), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Peter A. McSweeney(Mesoblast (United States)), Edward Agura(Baylor University), Michael A. Pulsipher(Primary Children's Hospital), William Bensinger(Swedish Medical Center), Mohamed L. Sorror(University of Washington Medical Center)
Cited by 105
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k